Remission, Glucocorticoid Toxicity, Health-Related Quality of Life, and Safety Outcomes in Patients with Renal Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis

被引:0
|
作者
Geetha, Duvuru [1 ]
Cortazar, Frank [2 ]
Bruchfeld, Annette [3 ]
Karras, Alexandre [4 ]
Merkel, Peter [5 ]
Jayne, David [6 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] New York Nephrol, Watervliet, NY USA
[3] Karolinska Inst, Stockholm, Sweden
[4] HEGP APHP, Paris, France
[5] Univ Penn, Philadelphia, PA USA
[6] Univ Cambridge, Cambridge, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0683
引用
收藏
页码:1363 / 1364
页数:2
相关论文
共 50 条
  • [41] Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
    Robson, Joanna C.
    Dawson, Jill
    Cronholm, Peter F.
    Milman, Nataliya
    Kellom, Katherine S.
    Ashdown, Susan
    Easley, Ebony
    Farrar, John T.
    Gebhart, Don
    Lanier, Georgia
    McAlear, Carol A.
    Peck, Jacqueline
    Luqmani, Raashid A.
    Shea, Judy A.
    Tomasson, Gunnar
    Merkel, Peter A.
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 17 - 34
  • [42] EFFECT OF AVACOPAN ON RELAPSE RATES AND RELAPSE-FREE TIME IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS, RESULTS OF THE PHASE 3 ADVOCATE STUDY
    Merkel, P. A.
    Yue, H.
    deGoma, E.
    Bekker, P.
    Jayne, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 120 - 120
  • [43] C5AR INHIBITOR AVACOPAN IN ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY (ANCA) VASCULITIS: PHASE II OUTCOMES OF SAFETY, RENAL PARAMETERS, AND QUALITY OF LIFE
    Schall, Thomas
    Potarca, Antonia
    Hillson, Jan
    Bekker, Pirow
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 582 - 582
  • [44] A Real-World Descriptive Study of Renal Outcomes Among Patients with ANCA-Associated Vasculitis Initiating Remission Induction Therapy
    Oh, Sam
    Inguva, Sushmitha
    Rane, Pallavi
    Tumminello, Brian
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4715 - 4717
  • [45] The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
    Strand, Vibeke
    Jayne, David R. W.
    Horomanski, Audra
    Yue, Huibin
    Bekker, Pirow
    Merkel, Peter A.
    LANCET RHEUMATOLOGY, 2023, 5 (08): : E451 - E460
  • [46] Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort
    Carranza-Enriquez, Fabian
    Antonio Meade-Aguilar, Jose
    Hinojosa-Azaola, Andrea
    CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2809 - 2816
  • [47] Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort
    Fabián Carranza-Enríquez
    José Antonio Meade-Aguilar
    Andrea Hinojosa-Azaola
    Clinical Rheumatology, 2022, 41 : 2809 - 2816
  • [48] A CROSS-SECTIONAL STUDY OF HEALTH-RELATED QUALITY OF LIFE ASSESSED BY THE SF-36 AND THE EQ-5D-5L IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Hirahara, S.
    Katsumata, Y.
    Harigai, M.
    Kawaguchi, Y.
    Yamanaka, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1099 - 1100
  • [49] Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial
    Oliva, Esther Natalie
    Platzbecker, Uwe
    Garcia-Manero, Guillermo
    Mufti, Ghulam J.
    Santini, Valeria
    Sekeres, Mikkael A.
    Komrokji, Rami S.
    Shetty, Jeevan K.
    Tang, Derek
    Guo, Shien
    Liao, Weiqin
    Zhang, George
    Ha, Xianwei
    Ito, Rodrigo
    Lord-Bessen, Jennifer
    Backstrom, Jay T.
    Fenaux, Pierre
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [50] The ANCA-Associated Vasculitis Patient-Reported Outcome (AAV-PRO) Captures Depression and Health-Related Quality of Life More Than Disease Activity and Damage
    Maunz, Annika
    Henes, Joerg
    Robson, Joanna
    Jacoby, Johann
    Hellmich, Bernhard
    Loeffler, Christian
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2663 - 2666